• Sign In
  • My Marketwire Account
  • Marketwire Resonate
  • News Dashboard 2.0
  • Mediahub
  • Personal Beat
  • Hot Off the Wire
• Register
• Français
• Marketwired Blog
• Careers
• Contact Marketwired

Browse By:

• Industry
  • Aerospace and Defense
  • Agriculture
  • Automotive
  • Chemicals
  • Computers and Software
  • Education and Training
  • Electronics and Semiconductors
  • Energy and Utilities
  • Environment
  • Financial Services
  • Food and Beverage
  • Government
  • Lifestyle and Leisure
  • Manufacturing and Production
  • Media and Entertainment
  • Medical and Healthcare
  • Pharmaceuticals and Biotech
  • Professional Services
  • Real Estate and Construction
  • Retail
  • Sports
  • Telecom
  • Transportation and Logistics
  • Travel and Hospitality
• Topic
  • Associations
  • Bankruptcy
  • Class action
  • Conference calls
  • Dividends
  • Earnings
  • Earnings projections
  • Financing agreements
  • Initial public offerings
  • Investment opinion
  • Management changes
  • Media advisory
  • Mergers and acquisitions
  • Special news events
  • Stock splits
  • Stock/other market news
  • Trade shows
  • Webcasts
• Type
  • News Releases
  • Media Advisories
  • Feature Packs
  • Webcasts
  • Social Media 2.0

News Room: Biotech

Cellana Appoints Michael J. Kamdar as President
SAN DIEGO, CA and KAILUA-KONA, HI--(Marketwired - May 22, 2013) - Cellana, Inc., a leading developer of algae-based bioproducts for the pharmaceutical, nutraceutical, fuel and animal feed...(more)
Cellana, Inc.  
May 22, 2013 06:00 ET
 

 

Onyx Pharmaceuticals Announces Data Presentations at the 18th Congress of the European Hematology Association
SOUTH SAN FRANCISCO, CA--(Marketwired - May 21, 2013) -  Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced the upcoming presentation of data highlighting Kyprolis® (carfilzomib) for...(more)
Onyx Pharmaceuticals, Inc.  
May 21, 2013 16:00 ET
 

 

Pressure BioSciences, Inc. Reports Strong First Quarter 2013 Financial Results
SOUTH EASTON, MA--(Marketwired - May 21, 2013) - Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced financial results for the three-month period ended March 31...(more)
PRESSURE BIOSCIENCES, INC.  
May 21, 2013 13:25 ET
 

 

Jennerex Announces Completion of Enrollment in Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer
SAN FRANCISCO, CA--(Marketwired - May 21, 2013) - Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in...(more)
Jennerex  
May 21, 2013 12:01 ET
 

 

Ayasdi Recognized for 'Big Data' Innovation With Four Industry Awards
PALO ALTO, CA--(Marketwired - May 21, 2013) - Ayasdi (www.ayasdi.com) today announced that it has received several industry awards in the last few weeks, just four months after its official...(more)
Ayasdi  
May 21, 2013 10:00 ET
 

 

Novo Nordisk A/S - Share repurchase programme
BAGSVAERD, DENMARK--(Marketwired - May 21, 2013) - On 3 May 2013, Novo Nordisk initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no...(more)
Novo Nordisk A/S  
May 21, 2013 09:45 ET
 

 

BrainStorm Provides Update on Clinical Trial and Scientific Conference Activities
NEW YORK, NY and PETACH TIKVAH, ISRAEL--(Marketwired - May 21, 2013) - BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative...(more)
BrainStorm Cell Therapeutics, Inc.  
May 21, 2013 09:37 ET
 

 

Stellar Biotechnologies to Present at the Second Annual Marcum LLP Microcap Conference
PORT HUENEME, CA--(Marketwired - May 21, 2013) - Stellar Biotechnologies, Inc. (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that Frank Oaks, President & CEO and Darrell Brookstein...(more)
Stellar Biotechnologies, Inc.  
May 21, 2013 09:33 ET
 

 

SECFilings.com Insider Buy Breaking Alert: ChromaDex Director Buys 25,000 Shares in Open Market
REDONDO BEACH, CA--(Marketwired - May 21, 2013) -  ChromaDex Corporation (OTCQB: CDXC) Director Michael Brauser purchased 25,000 shares of common stock on the open market on May 13th, according...(more)
ChromaDex Corporation  
May 21, 2013 09:15 ET
 

 

Medistem, Inc. Appoints Herm Rosenman to Board of Directors
SAN DIEGO, CA--(Marketwired - May 21, 2013) - Medistem, Inc. (PINKSHEETS: MEDS), today announced that it has appointed Herm Rosenman to its Board of Directors and Chairman of the Audit Committee....(more)
Medistem Inc.  
May 21, 2013 09:00 ET